RARE
Ultragenyx Pharmaceutical Inc
Price:  
43.69 
USD
Volume:  
592,367.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Stock Forecast & Price Target

RARE Stock Price Forecast

The average stock forecast for Ultragenyx Pharmaceutical Inc (RARE) in the next 12 months is 91.75 USD. This price target corresponds to an upside of 109.99%. The range of stock forecasts for RARE is 48.48 - 147.00 USD. Based on the ratings of 26 analysts, the consensus recommendation for RARE is BUY.
Target Low Average Median High
Price (USD) 48.48 91.75 83.64 147.00
Upside 10.96% 109.99% 91.44% 236.46%

Recommendation Trends

The latest consensus rating for RARE is "BUY". This is the average recommendation of 26 analysts: 0 strong sell, 0 sell, 3 hold, 14 buy, 9 strong buy. In the previous period, 26 analysts also majorly recommmended "BUY" for RARE.

RARE Financial Stock Forecast

Revenue This Year
513.15M
18.17%
from 434.25M
Revenue Next Year
645.82M
25.86%
from 513.15M
EPS This Year
-6.50
-11.77%
from -7.37
EPS Next Year
-5.01
-22.99%
from -6.50